Pharma Giants Announce US Drug Price Cuts and Direct-to-Consumer Sales

Pharmaceutical Price Reductions and Direct Sales

• 💊 Several major pharmaceutical companies are now selling drugs directly to US patients, offering significant price cuts.
• 🎯 This initiative follows President Donald Trump's calls to lower drug prices and eliminate 'middlemen' such as pharmacies, insurers, and pharmacy benefit managers.
• 🌐 The Trump administration is planning to launch a government-run website, "Trump RX," in the upcoming year to further reduce prescription drug prices.
• 📈 US patients currently face the highest costs for prescription medicines globally, often paying nearly three times more than in other developed nations.

Company-Specific Drug Pricing Initiatives

• 🤝 AstraZeneca has agreed to sell some medicines at a discount to the government's Medicaid plan in exchange for tariff relief, with a commitment to invest $50 billion in US drug development over five years.
• 💸 Eli Lilly will offer its popular weight loss drug, Zetbound, directly to cash-paying customers via its website at discounted prices.
• diabetes drug OMIC for $499 per month for eligible cash-paying patients with type 2 diabetes through its own pharmacy.
• 🇺🇸 FISA has agreed to lower prescription drug prices within the Medicaid program compared to international pricing in exchange for tariff relief, and will invest $70 billion in R&D and domestic manufacturing.
• 💰 Roche is considering selling its prescription medicines directly to US consumers to reduce patient costs.
• 💲 Sanofi will offer a month's supply of any of its insulin products for $35 to all US patients with a valid prescription, irrespective of insurance status.